Halozyme Therapeutics (HALO) EBT Margin (2010 - 2026)
Halozyme Therapeutics (HALO) recorded EBT Margin of 59.23% in Q2 2026, down 3.69 percentage points from 62.92% a year earlier but up 11.36 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EBT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Halozyme Therapeutics' EBT Margin came in at 35.06% as of Jun 30, 2026, down 23.66 percentage points year-over-year; for FY2025, it came in at 33.43%, down 21.44 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -14.89 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 54.87% in FY2024 (+12.87 pp), 42.01% in FY2023 (+4.30 pp), 37.71% in FY2022 (-18.35 pp) and 56.06% in FY2021 (+7.74 pp).
- Quarterly EBT Margin has ranged from -22.32% in Q4 2025 to 63.98% in Q3 2021 over the past five years.
- On a year-over-year basis, EBT Margin has declined for three consecutive quarters, with an average year-over-year change of -5.55 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 31.90 percentage points in Q1 2022, against a drop of 82.12 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 47.87% (Q1 2026), -22.32% (Q4 2025) and 61.81% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 59.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.23% |
| Mar 31, 2026 | 47.87% |
| Dec 31, 2025 | -22.32% |
| Sep 30, 2025 | 61.81% |
| Jun 30, 2025 | 62.92% |
| Mar 31, 2025 | 54.30% |
| Dec 31, 2024 | 59.80% |
| Sep 30, 2024 | 56.93% |
| Jun 30, 2024 | 50.89% |
| Mar 31, 2024 | 49.02% |
| Dec 31, 2023 | 43.98% |
| Sep 30, 2023 | 47.10% |
| Jun 30, 2023 | 42.14% |
| Mar 31, 2023 | 32.22% |
| Dec 31, 2022 | 39.00% |
| Sep 30, 2022 | 35.27% |
| Jun 30, 2022 | 19.70% |
| Mar 31, 2022 | 63.45% |
| Dec 31, 2021 | 53.73% |
| Sep 30, 2021 | 63.98% |
API Access
Halozyme Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();